Stericycle is considering a potential sale after receiving takeover interest, Liana Baker and Ryan Gould of Bloomberg report, citing people with knowledge of the matter. The company is working with a financial adviser as it weighs options, sources told Bloomberg. The company could attract other medical waste management providers, as well as infrastructure funds, the people said. Shares of Stericycle are up 7%, or $2.96, to $47.71 following the report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRCL:
- Stericycle to Participate in Oppenheimer 19th Annual Industrial Growth Conference in May
- Stericycle to Participate in Stifel 2024 Investor Summit at WasteExpo in May
- Stericycle price target lowered to $50 from $57 at Truist
- Stericycle price target lowered to $55 from $62 at Baird
- Stericycle on track to realize $40M-$45M in-year cost savings